| Sign In to gain access to subscriptions and/or personal tools. |
Cholesterol homeostasis in the developing brain: a possible new target for ethanolDepartment of Environmental and Occupational Health Sciences, University of Washington, Seattle, USA, marinag{at}u.washington.edu
Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, USA, Department of Human Anatomy, Pharmacology and Forensic Medicine, University of Parma, Italy Cholesterol is an essential component of cell membranes and plays an important role in signal transduction. This brief overview presents evidence from the literature that ethanol may affect cholesterol homeostasis and that, in the developing brain, this may be involved in its developmental neurotoxicity. The effects caused by inborn errors of cholesterol synthesis and by in utero ethanol exposure present several similarities in humans (eg, Smith-Lemli-Opitz syndrome and fetal alcohol syndrome), as well as in animal models. Ethanol has a cholesterol-reducing effect on the cardiovascular system, and a protective effect against Alzheimer's disease, whose pathogenesis has been linked to altered cholesterol homeostasis in the brain. In vitro, ethanol affects several functions that are mediated by cholesterol and important for brain development, such as glial cell proliferation, synaptogenesis, neuronal survival and neurite outgrowth. The brain contains high levels of cholesterol, mostly synthesized in situ. Astrocytes produce large amounts of cholesterol that can be released by these cells and utilized by neurons to form synapses. Ethanol up-regulates the cholesterol transporter ATP binding cassette A1 and cholesterol efflux from primary astrocyte cultures without affecting cholesterol synthesis. Human & Experimental Toxicology (2007) 26, 355-360
Key Words: astrocytes cholesterol ethanol fetal alcohol syndrome
Human & Experimental Toxicology, Vol. 26, No. 4,
355-360 (2007) This article has been cited by other articles:
|
|||||||||||||||
